2ASG - Header Asymmetric Unit

HEADER MEMBRANE PROTEIN 23-AUG-05 2ASG

TITLE BINDING DOMAIN OF NON-COMPETITIVE INHIBITORS IN THE TITLE 2 ALPHA3BETA4 SUBTYPE OF NICOTINIC ACETYLCHOLINE RECEPTOR

COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: RESIDUES 269-291; COMPND 5 OTHER_DETAILS: ALPHA-3 SUBUNIT; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN; COMPND 8 CHAIN: B, D, E; COMPND 9 FRAGMENT: RESIDUES 262-284; COMPND 10 OTHER_DETAILS: BETA-4 SUBUNIT

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 6 ORGANISM_COMMON: HUMAN

KEYWDS ION-CHANNEL, LUMEN, ALPHA3BETA4, NACHR

EXPDTA THEORETICAL MODEL

AUTHOR K.JOZWIAK,S.RAVICHANDRAN,J.R.COLLINS,I.W.WAINER

REVDAT 1 13-SEP-05 2ASG 0

JRNL AUTH K.JOZWIAK,S.RAVICHANDRAN,J.R.COLLINS,I.W.WAINER JRNL TITL INTERACTION OF NONCOMPETITIVE INHIBITORS WITH AN JRNL TITL 2 IMMOBILIZED 34 NICOTINIC ACETYLCHOLINE RECEPTOR JRNL TITL 3 INVESTIGATED BY AFFINITY CHROMATOGRAPHY, JRNL TITL 4 QUANTITATIVE-STRUCTURE ACTIVITY RELATIONSHIP JRNL TITL 5 ANALYSIS, AND MOLECULAR DOCKING JRNL REF J.MED.CHEM. V. 47 4008 2004 JRNL REFN ASTM JMCMAR US ISSN 0022-2623

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AMBER 6.0 REMARK 3 AUTHORS : PEARLMAN,CASE,CALDWELL,ROSS,CHEATHAM,FERGUSON, REMARK 3 SEIBEL,SINGH,WEINER,KOLLMAN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 2ASG COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-2005. REMARK 100 THE RCSB ID CODE IS RCSB034260.

REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THE STRUCTURE WAS PROCESSED USING SYBYL, VERSION 6.8, REMARK 220 7.0

REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS B 48 ILE B 49 145.64 REMARK 500 THR C 72 GLU C 73 148.10

REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE RESIDUE AT THE C-TERMINUS IS METHYLAMIDATED IN CHAINS REMARK 999 A, B, C, D AND E

DBREF 2ASG A 2 24 UNP P32297 ACHA3_HUMAN 269 291 DBREF 2ASG C 52 74 UNP P32297 ACHA3_HUMAN 269 291 DBREF 2ASG B 27 49 UNP P30926 ACHB4_HUMAN 262 284 DBREF 2ASG D 77 99 UNP P30926 ACHB4_HUMAN 262 284 DBREF 2ASG E 102 124 UNP P30926 ACHB4_HUMAN 262 284

SEQADV 2ASG ACE A 1 UNP P32297 ACETYLATION SEQADV 2ASG NME A 25 UNP P32297 SEE REMARK 999 SEQADV 2ASG ACE C 51 UNP P32297 ACETYLATION SEQADV 2ASG NME C 75 UNP P32297 SEE REMARK 999 SEQADV 2ASG ACE B 26 UNP P30926 ACETYLATION SEQADV 2ASG NME B 50 UNP P30926 SEE REMARK 999 SEQADV 2ASG ACE D 76 UNP P30926 ACETYLATION SEQADV 2ASG NME D 100 UNP P30926 SEE REMARK 999 SEQADV 2ASG ACE E 101 UNP P30926 ACETYLATION SEQADV 2ASG NME E 125 UNP P30926 SEE REMARK 999

SEQRES 1 A 25 ACE GLU LYS VAL THR LEU CYS ILE SER VAL LEU LEU SER SEQRES 2 A 25 LEU THR VAL PHE LEU LEU VAL ILE THR GLU THR NME SEQRES 1 B 25 ACE GLU LYS MET THR LEU CYS ILE SER VAL LEU LEU ALA SEQRES 2 B 25 LEU THR PHE PHE LEU LEU LEU ILE SER LYS ILE NME SEQRES 1 C 25 ACE GLU LYS VAL THR LEU CYS ILE SER VAL LEU LEU SER SEQRES 2 C 25 LEU THR VAL PHE LEU LEU VAL ILE THR GLU THR NME SEQRES 1 D 25 ACE GLU LYS MET THR LEU CYS ILE SER VAL LEU LEU ALA SEQRES 2 D 25 LEU THR PHE PHE LEU LEU LEU ILE SER LYS ILE NME SEQRES 1 E 25 ACE GLU LYS MET THR LEU CYS ILE SER VAL LEU LEU ALA SEQRES 2 E 25 LEU THR PHE PHE LEU LEU LEU ILE SER LYS ILE NME

HET ACE A 1 3 HET NME A 25 3 HET ACE B 26 3 HET NME B 50 3 HET ACE C 51 3 HET NME C 75 3 HET ACE D 76 3 HET NME D 100 3 HET ACE E 101 3 HET NME E 125 3

HETNAM ACE ACETYL GROUP HETNAM NME METHYLAMINE

FORMUL 1 ACE 5(C2 H4 O) FORMUL 1 NME 5(C H5 N)

HELIX 1 1 GLU A 2 THR A 24 1 23 HELIX 2 2 GLU B 27 ILE B 49 1 23 HELIX 3 3 GLU C 52 VAL C 66 1 15 HELIX 4 4 VAL C 66 THR C 74 1 9 HELIX 5 5 GLU D 77 ILE D 99 1 23 HELIX 6 6 GLU E 102 ILE E 124 1 23

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000